ZYLOX-TONBRDG.MED.TECH.H1 (818) — Financial Flexibility Index
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Financial Flexibility Index of 1.04x as of December 2024. Free cash flow of €365.42 Million (operating CF €174.08 Million minus capex €191.34 Million) represents 1% of total liabilities (€351.56 Million). Check cash flow reinvestment rate of ZYLOX-TONBRDG.MED.TECH.H1 to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZYLOX-TONBRDG.MED.TECH.H1 Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for ZYLOX-TONBRDG.MED.TECH.H1 across 4 annual periods. For the full cash flow conversion analysis, see ZYLOX-TONBRDG.MED.TECH.H1 cash flow conversion.
Annual Financial Flexibility Index for ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
Year-by-year free cash flow to debt coverage for ZYLOX-TONBRDG.MED.TECH.H1. Explore 818 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.04x | €365.42 Million | €174.08 Million | €351.56 Million | ▲ +17.9% |
| 2023 | 0.88x | €289.36 Million | €98.44 Million | €328.32 Million | ▲ +160.6% |
| 2022 | 0.34x | €53.96 Million | €-91.32 Million | €159.54 Million | ▲ +231.7% |
| 2021 | -0.26x | €-26.61 Million | €-116.21 Million | €103.61 Million | — |